Novo Nordisk's pricing strategies during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of rate gouging, stating the stark distinction concerning U.S. selling prices and people in Europe and copyright.California biotech behemoth Amgen ditched options for an experimental weight loss pill in May